Abbott Laboratories

Abbott Laboratories EBITDA per Employee

The EBITDA per Employee of Abbott Laboratories (ABT) as of Oct 27, 2026 is 86,217.39 USD. In the previous year, EBITDA per Employee was 77,547.83 USD — a change of 11.18% (higher).

EBITDA per Employee

86,217.39USD

YoY

11.18%

Last updated:

EBITDA per Employee of Abbott Laboratories is 2025 86,217.39 USD. EBITDA per Employee of Abbott Laboratories was 2024 77,547.83 USD. It decreases by 11.18% higher compared to the previous year.

The Abbott Laboratories EBITDA per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Employee
Date
EBITDA per Employee
Jan 1, 2018
52,365.22 USD
Jan 1, 2019
56,756.52 USD
Jan 1, 2020
64,547.83 USD
Jan 1, 2021
97,800.00 USD
Jan 1, 2022
90,217.39 USD
Jan 1, 2023
75,208.70 USD
Jan 1, 2024
77,547.83 USD
Jan 1, 2025
86,217.39 USD
The Abbott Laboratories EBITDA per Employee history
YEAREBITDA per EmployeeYoY
86,217.39USD+11.18%
77,547.83USD+3.11%
75,208.70USD-16.64%
90,217.39USD-7.75%
97,800.00USD+51.52%
64,547.83USD+13.73%
56,756.52USD+8.39%
52,365.22USD+27.40%
41,104.35USD+24.43%
33,034.78USD+7.01%
30,869.57USD+2.28%
30,182.61USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Abbott Laboratories Stock analysis

What does Abbott Laboratories do? Abbott Laboratories is one of the largest companies in the healthcare industry worldwide. The company was founded in 1888 by Dr. Wallace C. Abbott, who aimed to develop innovative and high-quality medical products that would improve people's lives and treat illnesses. Abbott Laboratories' business model is based on the discovery, development, manufacturing, and marketing of healthcare products. These range from pharmaceuticals to diagnostic devices. The company operates in various areas, including pharmaceuticals, nutrition, diagnostics, medical technology, and animal health. In the pharmaceutical field, Abbott Laboratories is a leading provider of generic drugs as well as innovative medications specialized in treating conditions such as Parkinson's disease, cancer, or hypertension. The company is particularly known for developing medications focused on the medical needs of women, such as hormone replacement therapy or birth control pills. In the nutrition field, Abbott Laboratories leads in the development of food and supplements for specific target groups, such as premature infants, cancer patients, or those with digestive problems. Best-selling products include Similac baby formula and Ensure, a nutritional supplement for older adults. In the diagnostics field, Abbott Laboratories develops and manufactures medical diagnostic devices and systems for patient monitoring. This includes blood glucose meters, blood pressure monitors, test strips, and laboratory systems for diagnosing diseases such as diabetes, HIV, or hepatitis. Abbott Laboratories is also a significant player in the medical technology field. The company produces and distributes medical devices such as pacemakers, stents, or artificial joints. These are typically used by doctors and hospitals to optimize patient treatment. In the animal health field, Abbott Laboratories offers a wide range of products and services for agricultural farms and veterinarians. This includes animal medications, pet food, diagnostics, and other services aimed at maintaining the health and well-being of livestock. Over the years, Abbott Laboratories has received numerous awards for its products and achievements. The company is committed to improving the quality of life for people worldwide and contributes to optimizing healthcare. Abbott Laboratories is among the top 15 leading pharmaceutical and healthcare companies worldwide and currently employs around 103,000 people in over 160 countries. Abbott Laboratories is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Abbott Laboratories stock

EBITDA per Employee of Abbott Laboratories is 86,217.39 USD in 2025.

EBITDA per Employee of Abbott Laboratories changed from 77,547.83 USD to 86,217.39 USD, representing a 11.18% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Employee Abbott Laboratories since 2006 – with annual values, charts, and detailed analysis.

EBITDA per employee measures operating cash earnings generated per employee, showing workforce productivity before depreciation and financing effects.

EBITDA per Employee's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA per Employee's Abbott Laboratories historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — Abbott Laboratories

All Key Metrics — Abbott Laboratories